September 2023: The FDA notes reports of Ileus, a gastrointestinal disorder, following use of Ozempic
GLP-1 receptor agonists mimic this natural hormone, offering improved glycemic control for people with type 2 diabetes
While both drugs are effective, adding a third hormone (Glucagon) in Retatrutide brings a different side effect profile that researchers are still studying
While not yet commercially available, researchers working with this peptide follow the same injection site principles
Bring your symptom log Discuss whether dose reduction or pause is appropriate Discuss whether anxiety treatment (therapy, medication) is appropriate Step 5: Treat anxiety as a separate condition if needed
If you are unsure what else to add to your routine, we recommend using our online tool to get personalized suggestions based on your specific health goals